Search
AVITA Medical Inc
RCELAdd to Watchlist
13.210USD
-0.120-0.90%
Close 10-09 16:00（ET）
406.60MMarket Cap
LossP/E TTM
AVITA Medical Inc (RCEL) Stock Price Target & Forecast
Analyst Rating
Based on 4 analysts giving stock ratings to AVITA Medical Inc in the past month.
Buy
1 Strong Buy
2 Buy
0 Hold
0 Sell
1 Strong Sell
Target Price
12.333USD-6.64%
RCEL Analyst Recommendation Trends
In the current month, RCEL has received 2 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. RCEL average Analyst price target in the last month is 12.333.
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
1
1
1
1
1
1
1
1
2
2
2
3
3
3
3
3
0
0
1
1
2
2
2
2
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4
4
4
5
6
6
6
6
RCEL Analyst Rating for Peer Comparison
Updated: Oct 11, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Beigene Ltd
ONC
8
19
0
0
0
27
argenx SE
ARGX
10
13
3
0
0
26
Ionis Pharmaceuticals Inc
IONS
6
14
5
0
0
25
Insmed Inc
INSM
7
18
0
0
0
25
Tempus AI Inc
TEM
4
7
11
0
1
23
Kymera Therapeutics Inc
KYMR
9
12
2
0
0
23
Revolution Medicines Inc
RVMD
8
14
1
0
0
23
CRISPR Therapeutics AG
CRSP
4
8
10
0
0
22
Biontech SE
BNTX
4
13
5
0
0
22
IQVIA Holdings Inc
IQV
8
11
3
0
0
22
Financial Forecasting
Based on analysts' estimates, RCEL EPS is projected to reach -0.223 in FY2026Q3, following reported EPS of -0.249 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.34
-0.28
-0.29
-0.22
-0.19
Actual
-0.38
-0.35
-0.25
--
--
Surprise
-13.75%
-24.09%
+13.07%
--
--
FAQs
What is AVITA Medical Inc's expected revenue for the next quarter?
AVITA Medical Inc's expected revenue is 22.20M.
What is AVITA Medical Inc's price target?
Analysts forecast that AVITA Medical Inc's price target is USD 12.33, with the highest forecast at USD 14.00 and the lowest forecast at USD 11.00.
How have AVITA Medical IncRCEL's recent earnings per share performed?
The market expectation was USD -0.25, while AVITA Medical IncRCEL's earnings per share (EPS) for the previous quarter was USD -0.35. EPS for the next quarter is expected at USD -0.22.
What is the analyst rating for AVITA Medical Inc?
Based on the ratings of AVITA Medical Inc's stock from 4 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.